Johnson & Johnson’s Balversa therapy finally gets full FDA approval
The approval by the Federal Drug Agency of the bladder cancer therapy Balversa has taken a notch higher the search for more treatment options.
March 5, 2024
by Shem Oirere
World’s first malaria vaccination programme launched in West Africa
Demand for the GlaxoSmithKline’s RTS,S/ AS01 vaccine, in minimizing cases of malaria infections and deaths among children.
March 5, 2024
by Shem Oirere
Africa Vaccine Manufacturing Plans Receive Major Boost
Africa’s plan to manufacture at least 60% of its own vaccines to reduce dependence on imports has received a major boost after a financing initiative was launched to support investment in expanded vaccine production and supply within continent.
January 19, 2024
by SHEM OIRERE
Hope for sickle cell disease patients as gene therapy gets more approvals
After years of exploration on gene therapy for sickle cell disease (SCD) and transfusion-dependent β-thalassemia.
January 19, 2024
by SHEM OIRERE
Boost for CGT market as AztraZeneca collaborates with Cellectics
UK-based Anglo-Swedish multinational pharmaceutical and biotechnology company, AztraZeneca Plc, announced on November 1, a deal with another company in the fast-growing CGT market.
November 16, 2023
by Shem Oirere
South Africa’s Aspen Pharmacare boosts Africa’s healthcare distribution market with new deals
Aspen Pharmacare Holdings Ltd continues to scale up medical distribution deals with international drug manufacturers as it seeks to increase its share of the healthcare distribution market in South Africa and rest of Sub-Saharan Africa.
November 16, 2023
by Shem Oirere
New COVID 19 Treatment Options Amid Falling Reported New Cases
The proportion of countries reporting COVID 19 cases has been declining since mid-2022 even as testing for and reporting of new cases reduce hence impacting uptake of drugs and associated active pharmaceutical ingredients.
August 16, 2023
by SHEM OIRERE
Vaccinating against Malaria in Africa
Vaccinating against malaria is gaining traction among many countries in malaria-prone Africa region where four-year pilot scheme of administering a malaria vaccine on children has borne good results according to World Health Organization.
August 15, 2023
by SHEM OIRERE
Morocco pharmaceutical market outlook
Morocco, the second biggest pharmaceutical market in Africa after South Africa, has since the 2006 approval of a strengthened liberalization policy attracted private financing and investments.
June 8, 2023
by SHEM OIRERE
Astellas’ non-hormonal VMS therapy gets FDA approval
U.S. Food and Drug Administration has approved Veozah, the first neurokinin 3 receptor antagonist, to treat moderate to severe vasomotor symptoms.
June 8, 2023
by SHEM OIRERE
WHO Publishes Updated List of COVID-19 Medicines, APIs
The coronavirus disease 2019 (COVID-19) infections and deaths continue to be reported across the globe creating demand for more appropriate medicines and associated active pharmaceutical ingredients.
May 5, 2023
by SHEM OIRERE
WHO Prequalifies Ethionamide for Indian firm
The World Health Organization (WHO) in early April 2023 pre-qualified ethionamide, manufactured by Indian pharmaceutical company, Micro Labs Limited.
May 4, 2023
by SHEM OIRERE